HealthInvest Partners AB as of March 31, 2024
Portfolio Holdings for HealthInvest Partners AB
HealthInvest Partners AB holds 44 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merck & Co (MRK) | 10.7 | $18M | 134k | 131.95 | |
| Eli Lilly & Co. (LLY) | 9.8 | $16M | 21k | 777.96 | |
| UnitedHealth (UNH) | 6.9 | $11M | 23k | 494.70 | |
| Thermo Fisher Scientific (TMO) | 5.4 | $8.8M | 15k | 581.21 | |
| Neurocrine Biosciences (NBIX) | 3.6 | $6.0M | 44k | 137.92 | |
| Harmony Biosciences Hldgs In (HRMY) | 3.5 | $5.7M | 170k | 33.58 | |
| Stryker Corporation (SYK) | 3.3 | $5.4M | 15k | 357.87 | |
| Amgen (AMGN) | 3.3 | $5.4M | 19k | 284.32 | |
| Abbvie (ABBV) | 3.3 | $5.3M | 29k | 182.10 | |
| Boston Scientific Corporation (BSX) | 3.2 | $5.3M | 77k | 68.49 | |
| Regeneron Pharmaceuticals (REGN) | 3.2 | $5.2M | 5.4k | 962.49 | |
| AmerisourceBergen (COR) | 3.0 | $5.0M | 20k | 242.99 | |
| Molina Healthcare (MOH) | 3.0 | $4.9M | 12k | 410.83 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.9 | $4.7M | 11k | 418.01 | |
| Option Care Health Com New (OPCH) | 2.7 | $4.5M | 133k | 33.54 | |
| Anthem (ELV) | 2.3 | $3.8M | 7.4k | 518.54 | |
| Gilead Sciences (GILD) | 2.3 | $3.8M | 52k | 73.25 | |
| Dex (DXCM) | 2.2 | $3.6M | 26k | 138.70 | |
| Mirum Pharmaceuticals (MIRM) | 1.9 | $3.1M | 123k | 25.12 | |
| Cardinal Health (CAH) | 1.9 | $3.1M | 28k | 111.90 | |
| Amicus Therapeutics (FOLD) | 1.8 | $3.0M | 252k | 11.78 | |
| Fusion Pharmaceuticals (FUSN) | 1.8 | $3.0M | 139k | 21.32 | |
| Ionis Pharmaceuticals (IONS) | 1.7 | $2.8M | 64k | 43.35 | |
| Immunocore Hldgs Ads (IMCR) | 1.6 | $2.7M | 41k | 65.00 | |
| Intra Cellular Therapies (ITCI) | 1.6 | $2.6M | 38k | 69.20 | |
| Iqvia Holdings (IQV) | 1.5 | $2.5M | 10k | 252.89 | |
| Edwards Lifesciences (EW) | 1.4 | $2.4M | 25k | 95.56 | |
| Shockwave Med (SWAV) | 0.9 | $1.5M | 4.8k | 325.63 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.9 | $1.5M | 38k | 39.24 | |
| Cabaletta Bio (CABA) | 0.8 | $1.3M | 78k | 17.06 | |
| Arcellx Common Stock (ACLX) | 0.7 | $1.2M | 18k | 69.55 | |
| Krystal Biotech (KRYS) | 0.7 | $1.2M | 6.6k | 177.93 | |
| Bridgebio Pharma (BBIO) | 0.7 | $1.2M | 38k | 30.92 | |
| EXACT Sciences Corporation (EXAS) | 0.7 | $1.1M | 16k | 69.06 | |
| Merus N V (MRUS) | 0.7 | $1.1M | 24k | 45.03 | |
| Inspire Med Sys (INSP) | 0.6 | $1.0M | 4.8k | 214.79 | |
| Cytokinetics Com New (CYTK) | 0.6 | $982k | 14k | 70.11 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $945k | 3.5k | 267.04 | |
| Macrogenics (MGNX) | 0.4 | $726k | 49k | 14.72 | |
| Akero Therapeutics (AKRO) | 0.4 | $617k | 24k | 25.26 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.4 | $615k | 96k | 6.38 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.3 | $530k | 22k | 23.65 | |
| Morphic Hldg (MORF) | 0.3 | $526k | 15k | 35.20 | |
| Mersana Therapeutics (MRSN) | 0.3 | $448k | 100k | 4.48 |
